DuPont De Nemours (DD) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Net sales for Q2 2025 rose 3% year-over-year to $3.3 billion, with 2% organic growth, led by strong performance in electronics, healthcare, and water end-markets.
Operating EBITDA increased 8% to $859 million, with adjusted EPS up 15% to $1.12, driven by higher segment earnings and a lower tax rate.
A $768 million goodwill impairment in IndustrialsCo led to a six-month net loss of $512 million, despite strong segment results.
A proposed $875 million settlement with New Jersey for environmental claims resulted in a $177 million pre-tax charge in Q2 2025.
The Electronics (Qnity) spin-off is targeted for November 1, 2025, with management and board finalized and internal separations underway.
Financial highlights
Q2 2025 net sales: $3.3 billion (up 3% year-over-year); operating EBITDA: $859 million (up 8%); adjusted EPS: $1.12 (up 15%).
Operating EBITDA margin expanded 120 basis points to 26.4% year-over-year.
Transaction-adjusted free cash flow was $433 million, with a 93% conversion rate.
Net income from continuing operations was $238 million, up 35% year-over-year.
Q2 2025 gross margin was 37%; cost of sales as a percentage of net sales remained flat at 63%.
Outlook and guidance
Full-year 2025 guidance: net sales ~$12.85 billion, operating EBITDA ~$3.36 billion, adjusted EPS ~$4.40, including a $20 million net tariff impact.
Q3 2025 guidance: net sales ~$3.32 billion, operating EBITDA ~$875 million, adjusted EPS ~$1.15.
Organic sales growth expected at 3-4% for FY25; cash conversion expected to exceed 90%.
Management expects sufficient liquidity, supported by $1.8 billion in cash and $2.0 billion in working capital as of June 30, 2025.
Capital structure actions, including potential debt repayments or exchanges, are being considered for the Electronics separation.
Latest events from DuPont De Nemours
- Board size reduced to ten after a director resignation; all other nominees remain.DD
Proxy filing15 Apr 2026 - 2025 delivered margin expansion and double-digit EPS growth; 2026 outlook strong for sales and cash flow.DD
Q4 202511 Apr 2026 - Annual meeting to vote on directors, pay, auditor, and reverse stock split amid governance focus.DD
Proxy filing10 Apr 2026 - Key proposals—director elections, pay, auditor, and reverse split—recommended for approval.DD
Proxy filing10 Apr 2026 - Proxy covers director elections, executive pay, auditor ratification, and a reverse stock split.DD
Proxy filing23 Mar 2026 - Strong growth and margin gains offset by a $768M goodwill impairment charge.DD
Q1 20253 Feb 2026 - Adjusted EPS up 14% and full-year guidance raised amid electronics-driven growth.DD
Q2 20242 Feb 2026 - Q3 net sales up 4%, EBITDA up 11%, and full-year guidance raised as business separations progress.DD
Q3 202416 Jan 2026 - Strong 2024 results, margin gains, and Electronics separation set up continued 2025 growth.DD
Q4 20248 Jan 2026 - Proxy details director elections, CEO transition, and strong 2024 results with ESG focus.DD
Proxy Filing1 Dec 2025